Search Results - "Quilliet, L."

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type by Camenzind, Edoardo, Boersma, Eric, Wijns, William, Mauri, Laura, Rademaker-Havinga, Tessa, Ordoubadi, Farzin Fath, Suttorp, Maarten J, Al Kurdi, Mohammad, Steg, Ph Gabriel

“…To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to…”
Get full text

Effect of time to treatment and age on one year mortality in acute STEMI: difference between thrombolysis and primary percutaneous coronary intervention by de Labriolle, A, Pacouret, G, Giraudeau, B, Fremont, B, Desveaux, B, Quilliet, L, Fauchier, L, Charbonnier, B

“…Summary Context Although thrombolysis (THL) and primary percutaneous coronary intervention (PPCI) are two validated options in reperfusion algorithms for…”
Get full text

P1847Comparing outcomes and complications between transfemoral TAVI performed with or without echoguided puncture by Bouteau, J, Bourguignon, T, Caze, C, Quilliet, L, Ivanes, F, Desveaux, B, Clerc, J M, Saint Etienne, C

“…Abstract Objective Transcatheter Aortic Valve Replacement (TAVI) has become the reference procedure in intermediate or high surgical risk patients with…”
Get full text

Development of a claims-based EuroSCORE II in patients with aortic stenosis needing surgical or transcatheter aortic valve replacement using electronic hospital records: a nationwide study by Fauchier, L, Bisson, A, Deharo, P, Bodin, A, Herbert, J, Lacour, T, Quilliet, L, Ivanes, F, Clerc, J.M, Saint Etienne, C, Bourguignon, T, Babuty, D, Bernard, A

Get full text

prognostic evaluation of patients benefiting from a trans aortic valve replacement according to the type of aortic stenosis by Lacout, M, David, C, Bernard, A, Saint Etienne, C, Clerc, JM, Quilliet, L, Dion, F, Caze, C

Get full text

Outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement by Fauchier, L, Bodin, A, Bisson, A, Herbert, J, Lacour, T, Saint Etienne, C, Clerc, J.M, Quilliet, L, Semaan, K, Ivanes, F, Pierre, B, Deharo, P, Babuty, D, Clementy, N

Get full text

Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis by Lantelme, P, Bisson, A, Lacour, T, Herbert, J, Ivanes, F, Bourguignon, T, Quilliet, L, Angoulvant, D, Harbaoui, B, Bonnet, M, Bernard, A, Babuty, D, Saint-Etienne, C, Deharo, P, Fauchier, L

Get full text

4070Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis by Fauchier, L, Bernard, A, Bisson, A, Lacour, T, Herbert, J, Ivanes, F, Bourguignon, T, Clerc, J M, Quilliet, L, Guillon Grammatico, L, Angoulvant, D, Saint Etienne, C, Babuty, D

“…Abstract Patients undergoing transcatheter aortic valve replacement (TAVR) may have concomitant mitral regurgitation (MR). The impact of MR at baseline or…”
Get full text

P1794Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement by Fauchier, L, Bisson, A, Herbert, J, Lacour, T, Ivanes, F, Bourguignon, T, Clerc, J M, Quilliet, L, Lantelme, P, Angoulvant, D, Babuty, D, Guillon Grammatico, L, Bernard, A, Saint Etienne, C

“…Abstract Risk-benefit assessment for transcatheter aortic valve replacement (TAVR) is still a matter of debate. A sizeable group of patients do not fully…”
Get full text

Coronary stenosis before TAVR is not necessarily associated with a poorer one-year prognosis and can be medically managed by Bensaid, R., Caze, C., Ternant, D., Saint-Etienne, C., Desveaux, B., Bourguignon, T., Clerc, J.M., Quilliet, L., Ivanes, F.

Get full text

Transaortic valvular replacement prognosis according to aortic stenosis category by David, C., Lacout, M., Caze, C., Saint Etienne, C., Clerc, J.M., Quilliet, L., Ivanes, F., Bernard, A.

Get full text

Rare cause of pure aortic regurgitation: congenital quadricuspid aortic valve by PAEMELAERE, J. M., DESVEAUX, B., MAILLARD, L., QUILLIET, L., RAYNAUD, P. H.

Get full text

Single infusion of intravenous cibenzoline in the treatment of supraventricular tachyarrhythmias following heart surgery. A double-blind placebo-controlled parallel study by Ollitrault, J, Quilliet, L, Scheck, F, Lelong, B, Richard, A, Jarry, G, Guize, L

“…The efficacy and safety of a single infusion of cibenzoline, a class I antiarrhythmic drug, were assessed in 86 patients presenting with a supraventricular…”
Get more information

The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions by Lefèvre, Thierry, Ormiston, John, Guagliumi, Giulio, Schultheiss, Heinz-Peter, Quilliet, Laurent, Reimers, Bernhard, Brunel, Philippe, Wijns, Williams, Buettner, H J, Hartmann, F, Veldhof, Susan, Miquel, Karin, Su, Xiaolu, van der Giessen, Willem J

“…The goal of this study was to evaluate the safety and performance of the Multi-Link Frontier coronary bifurcation stent system (Guidant Corp., Santa Clara,…”
Get full text

37 Detection of ischemia by multilayer strain at the acute phase of a myocardial infarction by Bernard, Anne, Bailleul, X., Ivanes, F., Dion, F., Saint-Etienne, C., Pacouret, G., Quilliet, L., Desveaux, B., Angoulvant, D.

Get full text

Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study by Brochier, M L, Quilliet, L, Kulbertus, H, Materne, P, Letac, B, Cribier, A, Monassier, J P, Sacrez, A, Favier, J P

“…The efficacy of a single intravenous bolus of anisoylated plasminogen streptokinase activator complex (APSAC 30U in 4 to 5 minutes) versus an intravenous…”
Get full text

Dilated cardiomyopathy, diabetes and deafness related to a mutation of mitochondrial DNA by Ferreira-Maldent, N, Maillot, F, Quilliet, L, Guilmot, J L, Charbonnier, B

“…Mitochondrial diseases may cause hypertrophic cardiomyopathy or, less commonly, dilated cardiomyopathy. The authors describe a case of a 46 year old woman with…”
Get more information

Transvenous interruption of the inferior vena cava. New model of vena cava filter. Preliminary results in 35 cases by Castellani, L, Nicaise, H, Pietri, J, Quilliet, L, Desvaux, B, Alison, D

“…Partial interruption of inferior vena cava (I.C.V.) forms an integral part of treatment of thromboembolic disease. The most frequently used filter worldwide is…”
Get more information

Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs by Sellier, P, Quilliet, L

“…Bepridil (Cordium) is a calcium channel blocker which has been demonstrated to be effective in the preventive treatment of angina. Few controlled trials have…”
Get more information

Comparative study of the efficacy and tolerability of bepridil and diltiazem in unstable angina. 277 patients by Bory, M, Quilliet, L

“…Bepridil has been used only rarely in unstable angina since its long half-life could imply a delayed action. A loading dose could deal with this disadvantage…”
Get more information